A phase II study of continuous infusion recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma in first remission. [electronic resource]
Producer: 19940601Description: 2707-14 p. digitalISSN:- 0006-4971
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Cyclophosphamide -- therapeutic use
- Doxorubicin -- therapeutic use
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- adverse effects
- Humans
- Infections
- Length of Stay
- Lymphoma, Non-Hodgkin -- therapy
- Male
- Middle Aged
- Neutrophils -- pathology
- Prednisone -- therapeutic use
- Prospective Studies
- Recombinant Proteins -- adverse effects
- Remission Induction
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.